2019

  1.  Firczuk M, Bajor M, Graczyk-Jarzynka A, Fidyt K, Goral A, Zagozdzon R. Harnessing altered oxidative metabolism in cancer by augmented prooxidant therapy. Cancer Lett. 2019 Dec 4. pii: S0304-3835(19)30601-9. doi: 10.1016/j.canlet.2019.11.037. [Epub ahead of print] PubMed PMID: 31811907.
  2. Rywik TM, Braniewska A, Kowalik I, Firczuk M, Kozar-Kaminska K, Wojciechowska A, Kasprzyk-Pawelec A, Sobieszczanska-Malek M, Leszek P, Rozentryt P, Zielinski T. Trajectory of the circulating endothelial progenitor cell levels and their association with acute rejection after heart transplantation. Pol Arch Intern Med. 2019 Nov 28. doi: 10.20452/pamw.15072. [Epub ahead of print] PubMed PMID: 31777401.
  3. Sosnowska A, Czystowska-Kuzmicz M, Golab J. Extracellular vesicles released by ovarian carcinoma contain arginase 1 that mitigates antitumor immune response. Oncoimmunology. 2019 Aug 20;8(11):e1655370. doi: 10.1080/2162402X.2019.1655370. eCollection 2019. PubMed PMID: 31646104; PubMed Central PMCID: PMC6791438.
  4. Sieńko J, Teliga-Czajkowska J, Przytula E, Czajkowski K, Smolarczyk R, Nowis D. Peroxiredoxin-1 as a prognostic factor in patients with ovarian cancer. Ann Agric Environ Med. 2019 Sep 19;26(3):415-419. doi: 10.26444/aaem/105899. Epub 2019 Apr 1. PubMed PMID: 31559796.
  5. Bobrowicz M, Zagozdzon R, Domagala J, Vasconcelos-Berg R, Guenova E, Winiarska M. Monoclonal Antibodies in Dermatooncology-State of the Art and Future Perspectives. Cancers (Basel). 2019 Sep 24;11(10). pii: E1420. doi: 10.3390/cancers11101420. Review. PubMed PMID: 31554169; PubMed Central PMCID: PMC6826541.
  6. Mazur M, Dymek B, Koralewski R, Sklepkiewicz P, Olejniczak S, Mazurkiewicz M, Piotrowicz M, Salamon M, Jędrzejczak K, Zagozdzon A, Czestkowski W, Matyszewski K, Borek B, Bartoszewicz A, Pluta E, Rymaszewska A, Mozga W, Stefaniak F, Dobrzański P, Dzwonek K, Golab J, Golebiowski A, Olczak J. Development of Dual Chitinase Inhibitors as Potential New Treatment for Respiratory System Diseases. J Med Chem. 2019 Aug 8;62(15):7126-7145. doi: 10.1021/acs.jmedchem.9b00681. Epub 2019 Jul 23. PubMed PMID: 31291098.
  7. Czystowska-Kuzmicz M, Sosnowska A, Nowis D, Ramji K, Szajnik M, Chlebowska-Tuz J, Wolinska E, Gaj P, Grazul M, Pilch Z, Zerrouqi A, Graczyk-Jarzynka A, Soroczynska K, Cierniak S, Koktysz R, Elishaev E, Gruca S, Stefanowicz A, Blaszczyk R, Borek B, Gzik A, Whiteside T, Golab J. Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma. Nat Commun. 2019 Jul 5;10(1):3000. doi: 10.1038/s41467-019-10979-3. PubMed PMID: 31278254; PubMed Central PMCID: PMC6611910.
  8. Szczepaniak A, Machnicki M, Gniot M, Pępek M, Rydzanicz M, Płoski R, Kaźmierczak M, Stokłosa T, Lewandowski K. Germline missense NF1 mutation in an elderly patient with a blastic plasmacytoid dendritic cell neoplasm. Int J Hematol. 2019 Jul;110(1):102-106. doi: 10.1007/s12185-019-02642-w. Epub 2019 Apr 11. PubMed PMID: 30977107.
  9. Sasi BK, Martines C, Xerxa E, Porro F, Kalkan H, Fazio R, Turkalj S, Bojnik E, Pyrzynska B, Stachura J, Zerrouqi A, Bobrowicz M, Winiarska M, Priebe V, Bertoni F, Mansouri L, Rosenquist R, Efremov DG. Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphoma. Leukemia. 2019 Oct;33(10):2416-2428. doi: 10.1038/s41375-019-0442-8. Epub 2019 Mar 14. PubMed PMID: 30872780.
  10. Fidyt K, Pastorczak A, Goral A, Szczygiel K, Fendler W, Muchowicz A, Bartlomiejczyk MA, Madzio J, Cyran J, Graczyk-Jarzynka A, Jansen E, Patkowska E, Lech-Maranda E, Pal D, Blair H, Burdzinska A, Pedzisz P, Glodkowska-Mrowka E, Demkow U, Gawle-Krawczyk K, Matysiak M, Winiarska M, Juszczynski P, Mlynarski W, Heidenreich O, Golab J, Firczuk M. Targeting the thioredoxin system as a novel strategy against B-cell acute lymphoblastic leukemia. Mol Oncol. 2019 May;13(5):1180-1195. doi: 10.1002/1878-0261.12476. Epub 2019 Apr 5. PubMed PMID: 30861284; PubMed Central PMCID: PMC6487705.
  11. Wolosz D, Walczak A, Szparecki G, Dwojak M, Winiarska M, Wolinska E, Gornicka B. Deleted in Liver Cancer 2 (DLC2) protein expression in hepatocellular carcinoma. Eur J Histochem. 2019 Feb 18;63(1). doi: 10.4081/ejh.2019.2981. PubMed PMID: 30827083; PubMed Central PMCID: PMC6383041.
  12. Sienko J, Gaj P, Czajkowski K, Nowis D. Peroxiredoxin-5 is a negative survival predictor in ovarian cancer. Ginekol Pol. 2019;90(1):1-6. doi: 10.5603/GP.2019.0001. PubMed PMID: 30756364.
  13. Pilch Z, Tonecka K, Skorzynski M, Sas Z, Braniewska A, Kryczka T, Boon L, Golab J, Meyaard L, Rygiel TP. The pro-tumor effect of CD200 expression is not mimicked by agonistic CD200R antibodies. PLoS One. 2019 Jan 17;14(1):e0210796. doi: 10.1371/journal.pone.0210796. eCollection 2019. PubMed PMID: 30653571; PubMed Central PMCID: PMC6336379.
  14. Graczyk-Jarzynka A, Goral A, Muchowicz A, Zagozdzon R, Winiarska M, Bajor M, Trzeciecka A, Fidyt K, Krupka JA, Cyran J, Szczygiel K, Efremov DG, Gobessi S, Jagielski A, Siudakowska K, Bobrowicz M, Klopotowska M, Barankiewicz J, Malenda A, Lech-Maranda E, Miazek-Zapala N, Skarzynski PH, Domagala A, Golab J, Firczuk M. Inhibition of thioredoxin-dependent H(2)O(2) removal sensitizes malignant B-cells to pharmacological ascorbate. Redox Biol. 2019 Feb;21:101062. doi: 10.1016/j.redox.2018.11.020. Epub 2018 Nov 29. PubMed PMID: 30576925; PubMed Central PMCID: PMC6302138.
  15. Marusiak AA, Prelowska MK, Mehlich D, Lazniewski M, Kaminska K, Gorczynski A, Korwat A, Sokolowska O, Kedzierska H, Golab J, Biernat W, Plewczynski D, Brognard J, Nowis D. Upregulation of MLK4 promotes migratory and invasive potential of breast cancer cells. Oncogene. 2019 Apr;38(15):2860-2875. doi: 10.1038/s41388-018-0618-0. Epub 2018 Dec 14. PubMed PMID: 30552384; PubMed Central PMCID: PMC6484767.